Envoy Medical (COCH) Stock: Buy, Sell, or Hold?
COCH - Envoy Medical, Inc. Class A Common Stock
$0.60
-0.05 (-7.91%)
▼
5d:
-7.57%
30d:
-17.47%
90d:
-10.08%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 09, 2026
17d
Get Alerted When COCH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: COCH shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: COCH shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: COCH is currently trading at $0.60, which is considered oversold relative to its 30-day fair value range of $0.64 to $0.71.
Technical Outlook: Technically, COCH is showing sideways momentum. The price is currently testing key support at $0.59. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.9% recently.
Market Sentiment: COCH scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.17 (+263.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, COCH is showing sideways momentum. The price is currently testing key support at $0.59. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.9% recently.
Market Sentiment: COCH scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.17 (+263.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.64 -
$0.71
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.9%)
- BULLISH: Trading 263.6% below Wall St target ($2.17)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.64 -
$0.71
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.59
Resistance Level
$0.69
Current Trend
Sideways
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.52
Wall Street Target
$2.17
(+263.6%)
Revenue Growth (YoY)
-34.6%
Share & Embed Analysis
Last updated: October 22, 2026 6:49 PM ET
Data refreshes hourly during market hours. Next update: 7:49 PM
Data refreshes hourly during market hours. Next update: 7:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COCH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 45 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 50 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 51 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 32 SELL |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 44 HOLD |
